Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
NEJM 362:402-415, 456, Cohen,J.A.,et al, 2010
Infective Endocarditis
Lancet 387:882-893, Cahill, T.J. & Prendergast, B.D., 2016
Electrophysiological Study with Prophylactic Pacing and Survival in Adults with Myotonic Dystrophy and Conduction System Disease
JAMA 307:1292-1301, Wahbi,K.,et al, 2012
LMNA Cardiomyopathy:Cell Biology and Genetics Meet Clinical Medicine
Disease Models & Mechanisms 4:562-568, Lu,J.T., et al, 2011
Electrophysiologic Findings in Multifocal Motor Neuropathy
Neurol 48:700-707, Katz,J.S.,et al, 1997
Conduction Block as an Early Sign of Reversible Injury in Ischemic Monomelic Neuropathy
Neurol 43:1126-1130, Kaku,D.A.,et al, 1993
A 23-Year-Olf Man With Progressibe Asymmetric Weakness and Numbness
Neurol 100:674-682, Kaplan,E.H.,et al, 2023
A 65-year-old man with Asymmetric Weakness and Parethesias
Neurol 93:856-861, Harada, Y.,et al, 2019
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
NEJM 362:387-401, 456, Kappos, L.,et al, 2010
A Reversible Paralysis
Lancet 360:1160, Maury,E.,et al, 2002
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Multifocal Motor Neuropathy
JNNP 60:599-603, Nobile-Orazio,E., 1996
The Clinical Correlates of High-Titer IgG Anti-GM1 Antibodies
Ann Neurol 35:234-237, Kornberg,A.J.,et al, 1994
Motor Neuron Diseases and Amyotrophic Lateral Sclerosis:GM1 Antibodies and Paraproteinemia
Neurol 43:418-420, Sanders,K.A.,et al, 1993
Multifocal Motor Neuropathy with Conduction Block:Is It a Distinct Clinical Entity?
Neurol 42:497-505, Lange,D.J.,et al, 1992
Amyotrophic Lateral Sclerosis and Lymphoma:Bone Marroe Examination and Other Diagnostic Tests
Neurol 42:1101-1102, Rowland,L.P.,et al, 1992